ISPOR EU 2024

Share on:

Sunday, November 17 - Wednesday, November 20, 2024

Conference website

Generating Evidence Toward Health and Well-Being

We are pleased to exhibit at ISPOR EU 2024. Our team of 20+ experts from across Europe and the US will also be attending, speaking, and presenting. Have a look at our schedule to see what you are interested in. Meet us at booth #1401.

We are excited to recognize Stephanie Earnshaw, Senior Fellow, who is serving as Chair of ISPOR's Educational Council

Scroll down to see what we're bringing to ISPOR EU and who will be attending.

Related Services

Short courses

Nov 17, 13:00-17:00

Short Course 015: Advanced Patient-Reported Outcomes

Speaker: Rebecca Crawford, Lynda Doward, Ari Gnanasakthy, Shanshan Qin, Nick Rockwood

Location: See event program

Presentations and Moderators

Giving voice to rare diseases during joint clinical assessment (JCA). Ling C, Hawe E, Stevenson A, Low EW.

Posters

Assessing the relationship between EQ-5D-3L index scores and disease-specific patient-reported outcome measures in eosinophilic oesophagitis. Msihid J, Joulain F, Hawe E, Burgess B, Thomas RB, Tilton ST.

Key features of economic models used in submissions to NICE in dermatology indications. Clemmet T, Campbell K, Basarir H.

Machine learning and artificial intelligence for supporting systematic reviews: a systematic review of recent methodological developments and recommendations for implementation. Marcano Belisario J, Lunan M, Hawe E, Thurairajah S.

Cost-effectiveness of cabotegravir long-acting for pre-exposure prophylaxis versus current use of daily oral tenofovir disoproxil fumarate/emtricitabine or no prep to prevent HIV-1 in individuals at high risk in Spain. Neches V, Campbell K, Coll P, Moreno Guillen S, Martinez-Sesmero JM, Lopez Segui F, O'Brien P, Davis A, Anderson SJ, Schroeder M, Vallejo-Aparicio LA.

Identifying the value drivers in obesity treatment: a targeted review of weight loss effects on health economic outcomes. Ronquest N, Zhang Y, Paret K, Armstrong S, Mostovoy L, Berggren R.

Economic evaluation of dupilumab versus standard of care for the treatment of adult patients with moderate-to-severe prurigo nodularis in the United States. Tavi J, Bahloul D, Kuznik A, Thomas RB, Knight C, Manga N, Sullivan SD.

HTA considerations for large language models in healthcare. Leonard C, Unsworth H, Warttig S, Gildea L, Mordin M, Ling C.

Comparison of cost-effectiveness model outcomes using two individual-level simulation models in obesity. Ni L, Harris M, Cotterill G, Hoog M, Basarir H, Deger K, van Hest N, Johansson E.

HTA requirements for medical technologies in Spain. Leonard C, Bhogal P, Menon AP, Ling C, Mordin M.

Using patient-level simulation to estimate long-term survival in idiopathic pulmonary fibrosis. Johannesen K, Herring WL, Chopra R, Elpers B, Dong O.

Hospitalization costs of common grade 3/4 adverse events associated with oncology treatments in the United States: 2024 update. Graham C, Erbe A.

Simulation of long-term impact of bempedoic acid and ezetimibe on atherosclerotic cardiovascular disease outcomes in Europe. Ray KK, Bardet A, Komen J, Manga N, Wolowacz S, Bregantini D, Becker C, Catapano AL.

Meta-analysis of pre-post studies: why standardised mean difference should be avoided. Burgess B, Leng X, Brizan J, Hawe E.

A systematic review of health economic evaluations of oral nutritional supplements as a single-component or multi-component intervention in older adults with or at risk of malnutrition. Desai A, Dong OM, Gautier S, Johnson T, Wong A, Osman AMY, Harvey J, Tran TH, Holladay Ford DM, Kerr KW, Aggarwal A, Mauskopf J.

Impact of the innovative licensing and access pathway (ILAP) designation on regulatory and health technology assessment (HTA) outcomes. D'Souza V, Bhogal P, Njue A.

Effect of adherence to hemophilia drug therapy on outcomes: a systematic literature review. Yubin Sohn A, Khanji C, Nuabor W, Gould T, Kim HK, Barrows SM, Herbel B, Njue A.

Systematic literature review of the economic burden of hemophilia A and B. Khanji C, Nuabor W, Kim HK, Yubin SA, Kim R, Njue A.

Systematic literature review of the humanistic burden of hemophilia A and B. Khanji C, Nuabor W, Kim HK, Yubin SA, Kim R, Njue A.

Cost-effectiveness of [177Lu]Lu-PSMA-617 in progressive PSMA-positive metastatic castration-resistant prostate cancer. Brockbank J, Hancock H, Khare A, Joshi P, Risson V.

Qualitative and quantitative evidence synthesis strategies to support JCA and IRA submissions. Khan S, Copley-Merriman K, Heyes A, Hawe E, Hartley L, Kallmes K.

Meet our experts

Susan Barker, BA

Senior Director, Marketing-Digital Strategy

Hasan Basarir, PhD

Senior Director, Health Economics

Preet Bhogal, MSc

Research Associate, Value and Access

Thor-Henrik Brodtkorb, PhD

Executive Director, Health Economics

Tom Clemmet, MSc

Research Health Economist

Kati Copley-Merriman, MBA

Vice President, Value and Access

Rebecca Crawford, MA

Director, Patient-Centered Outcomes Assessment

Valerie Derrien Ansquer, MA

Director, Surveys and Observational Studies

Frank Distler, MSc

Senior Director, Business Development

Lynda Doward, MRes

VP, European Head Patient-Centered Outcomes Assessment

Stephanie Earnshaw, PhD

Senior Vice President, Health Economics

Amanda Erbe

Amanda Erbe, MSc

Research Health Economist

Ari Gnanasakthy, MBA, MSc

Principal Scientist, Patient-Centered Outcomes Assessment

Christopher N. Graham, MS

Executive Director, Health Economics

Head, Data Analytics and Design Strategy

Faisal Latif, MSc

Head of Integrated Evidence Strategy

Caoimhe Leonard, MSc

Research Associate, Value and Access

Caroline Ling, PhD

Executive Director and HTA Specialist, Value and Access

Jose Marcano Belisario

Jose Marcano Belisario, PhD

Associate Director, Evidence Synthesis and Statistics

Decision Analytic Modeler/Research Health Economist

Vice President, Biostatistics

Bolu Olowoyo, BSc

Associate Director, Business Development

Rohan Parikh, PhD

Senior Director, Health Economics

Alyssa Pettey

Alyssa Pettey, MS

Senior Research Scientist

Christine Poulos, PhD

Senior Economist and Vice President, Health Preference Assessment

Shanshan Qin, PhD

Director, Psychometrics, Patient-Centered Outcomes Assessment

Nicholas Rockwood

Nicholas Rockwood, PhD

Senior Psychometrician, Patient-Centered Outcomes Assessment

Sarah Sauchelli Toran, PhD

Senior Researcher, Patient-Centered Outcomes Assessment

Martina Sluga-O'Callaghan, PhD

Director, Surveys and Observational Studies

Caroline Vass, PhD

Senior Economist

Verity Watson, PhD

Senior Research Economist

Diane Whalley, PhD

Executive Director, Patient-Centered Outcomes Assessment

Peter Wirth, BS

Vice President, Business Development